Buscar
11/05/2023
The Phosphorylation of Kv1.3: A Modulatory Mechanism for a Multifunctional Ion Channel
Navarro-Perez, M, Estadella, I, Benavente-Garcia, A, Orellana-Fernandez, R, Petit, A, Ferreres, JC, Felipe, A. The Phosphorylation of Kv1.3: A Modulatory Mechanism for a Multifunctional Ion Channel. Cancers. 2023; 15(10)DOI:10.3390/cancers15102716. PMID:37345053. IF:4.500(Q1/3D).
01/05/2023
Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study
Espinosa, I, D'Angelo, E, De Brot, L, Prat, J. Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study. HUMAN PATHOLOGY. 2023; 135DOI:10.1016/j.humpath.2023.02.006. PMID:36863690. IF:2.700(Q2/4D).
01/05/2023
Macrophage CD5L is a target for cancer immunotherapy
Sanchez-Moral, L, Paul, T, Martori, C, Font-Diaz, J, Sanjurjo, L, Aran, G, Tellez, E, Blanco, J, Carrillo, J, Ito, M, Tuttolomondo, M, Ditzel, HJ, Fumagalli, C, Tapia, G, Sidorova, J, Masnou, H, Fernandez-Sanmartin, MA, Lozano, JJ, Vilaplana, C, Rodriguez-Cortes, A, Armengol, C, Valledor, AF, Kremer, L, Sarriasa, MR. Macrophage CD5L is a target for cancer immunotherapy. EBioMedicine. 2023; 91DOI:10.1016/j.ebiom.2023.104555. PMID:37054630. IF:9.700(Q1/1D).
01/04/2023
Placental site trophoblastic tumor (PSTT): a case report and review of the literature
Zampacorta, C, Pasciuto, MP, Ferro, B, Lucidi, A, Maestro, AS, Espinosa, I, D'Angelo, E, Prat, J. Placental site trophoblastic tumor (PSTT): a case report and review of the literature. Pathologica. 2023; 115(2)DOI:10.32074/1591-951X-873. PMID:37114629. IF:(Q/D).
01/01/2023
CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study
Frezza A.M., Stacchiotti S., Chibon F., Coindre, JM, Italiano A., Romagnosa C., Bagué S., Dei Tos A.P., Braglia L., Palmerini E., Quagliuolo V., Broto J.M., Pousa, AL, Grignani G., Brunello A., Blay, JY, Beveridge R.D., Lugowska I., Lesluyes T., Maestro R., Merlo F.D., Casali P.G., Gronchi A.. CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study. Cancer Medicine. 2023; 12(2)DOI:10.1002/cam4.5015. PMID:35848358. IF:2.900(Q2/5D).
01/01/2023
Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models
Medina-Gutiérrez E., García-León A., Gallardo A., Álamo P., Alba-Castellón L., Unzueta U., Villaverde A., Vázquez E., Casanova I., Mangues R.. Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models. Cancers. 2023; 15(1)DOI:10.3390/cancers15010085. PMID:36612081. IF:4.500(Q1/3D).
01/01/2023
Validation of a Pathological Score for the Assessment of Bronchial Biopsies in Severe Uncontrolled Asthma: Beyond Blood Eosinophils
Cosio B.G., Shafiek H., Iglesias A., Mosteiro M., Gonzalez-Piñeiro A., Rodríguez M., García-Cosío M., Busto E., Martin J., Mejías L., Benito A., López Vilaro L., Gómez C.. Validation of a Pathological Score for the Assessment of Bronchial Biopsies in Severe Uncontrolled Asthma: Beyond Blood Eosinophils. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(8)DOI:10.1016/j.arbres.2023.05.014. PMID:37414638. IF:8.700(Q1/1D).
01/01/2023
Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease
Gené M., Cuatrecasas M., Amat I., Veiga J.A., Fernández Aceñero M.J., Fusté Chimisana V., Tarragona J., Jurado I., Fernández-Victoria R., Martínez Ciarpaglini C., Alenda González C., Zac C., Ortega de la Obra P., Fernández-Figueras M.T., Esteller M., Musulen E.. Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(10)DOI:10.3390/ijms24108655. PMID:37240002. IF:4.900(Q1/3D).